CDCA2 Inhibits Apoptosis and Promotes Cell Proliferation in Prostate Cancer and Is Directly Regulated by HIF-1α Pathway
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CDCA2 Inhibits Apoptosis and Promotes Cell Proliferation in Prostate Cancer and Is Directly Regulated by HIF-1α Pathway
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-05-19
DOI
10.3389/fonc.2020.00725
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ONECUT2 is a driver of neuroendocrine prostate cancer
- (2019) Haiyang Guo et al. Nature Communications
- CDCA2 promotes the proliferation of colorectal cancer cells by activating the AKT/CCND1 pathway in vitro and in vivo
- (2019) Yifei Feng et al. BMC CANCER
- Upregulation of CDCA5 promotes gastric cancer malignant progression via influencing cyclin E1
- (2018) Zhengyuan Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- KDM4B protects against obesity and metabolic dysfunction
- (2018) Yingduan Cheng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CDCA5 regulates proliferation in hepatocellular carcinoma and has potential as a negative prognostic marker
- (2018) Zhiqing Shen et al. OncoTargets and Therapy
- Distinct expression of CDCA3, CDCA5, and CDCA8 leads to shorter relapse free survival in breast cancer patient
- (2018) Nam Nhut Phan et al. Oncotarget
- Integrative epigenetic taxonomy of primary prostate cancer
- (2018) Suzan Stelloo et al. Nature Communications
- CDCA4, a downstream gene of the Nrf2 signaling pathway, regulates cell proliferation and apoptosis in the MCF‑7/ADM human breast cancer cell line
- (2017) Yuju Xu et al. Molecular Medicine Reports
- Repo-Man/PP1 regulates heterochromatin formation in interphase
- (2017) Inês J. de Castro et al. Nature Communications
- Overexpression of a novel candidate oncogene KIF14 correlates with tumor progression and poor prognosis in prostate cancer
- (2017) Yixiang Zhang et al. Oncotarget
- CDCA2 promotes lung adenocarcinoma cell proliferation and predicts poor survival in lung adenocarcinoma patients
- (2017) Run Shi et al. Oncotarget
- OSR1 is a novel epigenetic silenced tumor suppressor regulating invasion and proliferation in renal cell carcinoma
- (2017) Yixiang Zhang et al. Oncotarget
- UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
- (2017) Darshan S. Chandrashekar et al. NEOPLASIA
- Hypoxia-independent gene expression signature associated with radiosensitisation of prostate cancer cell lines by histone deacetylase inhibition
- (2016) Marte Jonsson et al. BRITISH JOURNAL OF CANCER
- Cell division cycle associated 1 as a novel prognostic biomarker and therapeutic target for oral cancer
- (2016) Phung Manh Thang et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- RASSF1A–LATS1 signalling stabilizes replication forks by restricting CDK2-mediated phosphorylation of BRCA2
- (2014) Dafni-Eleftheria Pefani et al. NATURE CELL BIOLOGY
- Global Gene Expression Profiling in Three Tumor Cell Lines Subjected to Experimental Cycling and Chronic Hypoxia
- (2014) Magdalena Olbryt et al. PLoS One
- In vivo modulation of hypoxia-inducible signaling by topographical helix mimetics
- (2014) B. B. Lao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunotherapy for Prostate Cancer: Lessons from Responses to Tumor-Associated Antigens
- (2014) Harm Westdorp et al. Frontiers in Immunology
- Metastasis Suppressor KISS1 Seems to Reverse the Warburg Effect by Enhancing Mitochondrial Biogenesis
- (2013) W. Liu et al. CANCER RESEARCH
- Exosomes secreted under hypoxia enhance invasiveness and stemness of prostate cancer cells by targeting adherens junction molecules
- (2013) Anand Ramteke et al. MOLECULAR CARCINOGENESIS
- Overexpression of CDCA2 in Human Squamous Cell Carcinoma: Correlation with Prevention of G1 Phase Arrest and Apoptosis
- (2013) Fumihiko Uchida et al. PLoS One
- Overexpression of cell cycle regulator CDCA3 promotes oral cancer progression by enhancing cell proliferation with prevention of G1 phase arrest
- (2012) Fumihiko Uchida et al. BMC CANCER
- Tumor Hypoxia Predicts Biochemical Failure following Radiotherapy for Clinically Localized Prostate Cancer
- (2012) M. Milosevic et al. CLINICAL CANCER RESEARCH
- Hypoxia and HIF-1 increase S100A8 and S100A9 expression in prostate cancer
- (2012) Sina Grebhardt et al. INTERNATIONAL JOURNAL OF CANCER
- The mutational landscape of lethal castration-resistant prostate cancer
- (2012) Catherine S. Grasso et al. NATURE
- Repo-Man Coordinates Chromosomal Reorganization with Nuclear Envelope Reassembly during Mitotic Exit
- (2011) Paola Vagnarelli et al. DEVELOPMENTAL CELL
- Hormone Depletion-Insensitivity of Prostate Cancer Cells Is Supported by the AR Without Binding to Classical Response Elements
- (2011) Mesfin Gonit et al. MOLECULAR ENDOCRINOLOGY
- Gadd45a Functions as a Promoter or Suppressor of Breast Cancer Dependent on the Oncogenic Stress
- (2010) J. S. Tront et al. CANCER RESEARCH
- The landscape of somatic copy-number alteration across human cancers
- (2010) Rameen Beroukhim et al. NATURE
- PML Nuclear Bodies
- (2010) V. Lallemand-Breitenbach et al. Cold Spring Harbor Perspectives in Biology
- The relevance of a hypoxic tumour microenvironment in prostate cancer
- (2009) Grant D. Stewart et al. BJU INTERNATIONAL
- Targeting the hypoxia-inducible factor (HIF) pathway in cancer
- (2009) Evon Poon et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- BCL-xL Is a Target Gene Regulated by Hypoxia-inducible Factor-1α
- (2009) Ni Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hypoxia Regulates Choline Kinase Expression through Hypoxia-Inducible Factor-1 Signaling in a Human Prostate Cancer Model
- (2008) K. Glunde et al. CANCER RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started